Literature DB >> 10563427

Primary CNS lymphoma: findings outside the brain.

U Herrlinger1.   

Abstract

In addition to the brain parenchyma and the leptomeninges, primary central nervous system lymphoma (PCNSL) can involve the posterior parts of the eye with ocular lymphoma in up to 20% of patients and lead to systemic dissemination of lymphoma in 7-8% of patients. Ocular lymphoma is diagnosed by slit lamp examination and requires treatment by ocular irradiation. However, the clinical significance of systemic dissemination, which occurs mainly in the end stage of the disease, appears to be disputable. Extensive systemic staging at the time of initial presentation proved to be unrewarding in the vast majority of studies. So far, only 10 patients have been reported with occult systemic lymphoma at time of initial presentation, and systemic lymphoma determined the course of the disease in none of them. Thus, initial staging procedures for patients with biopsy-confirmed PCNSL can be restricted to regular blood tests, including HIV testing, and slit lamp examination of the eye.

Entities:  

Mesh:

Year:  1999        PMID: 10563427     DOI: 10.1023/a:1006250317940

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  30 in total

1.  Clinical presentation and therapeutic outcome in 26 patients with primary CNS lymphoma.

Authors:  U Herrlinger; M Schabet; M Clemens; R D Kortmann; D Petersen; B E Will; R Meyermann; J Dichgans
Journal:  Acta Neurol Scand       Date:  1998-04       Impact factor: 3.209

2.  Primary malignant lymphomas of the central nervous system.

Authors:  J M Henry; R R Heffner; S H Dillard; K M Earle; R L Davis
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

3.  Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.

Authors:  D C Miller; F H Hochberg; N L Harris; M L Gruber; D N Louis; H Cohen
Journal:  Cancer       Date:  1994-08-15       Impact factor: 6.860

4.  Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome.

Authors:  J Glass; M L Gruber; L Cher; F H Hochberg
Journal:  J Neurosurg       Date:  1994-08       Impact factor: 5.115

5.  Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management.

Authors:  D H Char; B M Ljung; T Miller; T Phillips
Journal:  Ophthalmology       Date:  1988-05       Impact factor: 12.079

6.  Primary central nervous system lymphoma in Japan--a retrospective, co-operative study by CNS-Lymphoma Study Group in Japan.

Authors:  T Hayakawa; K Takakura; H Abe; T Yoshimoto; R Tanaka; K Sugita; H Kikuchi; T Uozumi; T Hori; H Fukui
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

7.  Combined modality therapy for primary CNS lymphoma.

Authors:  L M DeAngelis; J Yahalom; H T Thaler; U Kher
Journal:  J Clin Oncol       Date:  1992-04       Impact factor: 44.544

8.  The clinical spectrum of ocular lymphoma.

Authors:  K Peterson; K B Gordon; M H Heinemann; L M DeAngelis
Journal:  Cancer       Date:  1993-08-01       Impact factor: 6.860

Review 9.  Primary central nervous system lymphoma.

Authors:  F H Hochberg; D C Miller
Journal:  J Neurosurg       Date:  1988-06       Impact factor: 5.115

10.  Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06.

Authors:  C Schultz; C Scott; W Sherman; B Donahue; J Fields; K Murray; B Fisher; R Abrams; J Meis-Kindblom
Journal:  J Clin Oncol       Date:  1996-02       Impact factor: 44.544

View more
  9 in total

1.  Cauda equina syndrome due to large B-cell lymphoma: a case report.

Authors:  Vincenzo Belcastro; Silvio Bellcocchi; Carlo Patriarca; Gigliola Gini; Mirko Piola; Salvatore Barca; Marco Arnaboldi
Journal:  Neurol Sci       Date:  2016-01-11       Impact factor: 3.307

2.  Brain lesion and AIDS.

Authors:  J T Gage; E A Vance; P G Hildenbrand; T Mattison
Journal:  Proc (Bayl Univ Med Cent)       Date:  2000-10

3.  Lymphomatous meningosis diagnosed with [18F]-fluorodeoxyglucose-positron-emission tomography/CT.

Authors:  S Ceyssens; T Van den Wyngaert; P Blockx; L van den Hauwe; P M Parizel; L van den Hauwe; K Geens
Journal:  AJNR Am J Neuroradiol       Date:  2009-09-03       Impact factor: 3.825

Review 4.  Primary central nervous system lymphoma: from clinical presentation to diagnosis.

Authors:  U Herrlinger; M Schabet; M Bitzer; D Petersen; P Krauseneck
Journal:  J Neurooncol       Date:  1999-07       Impact factor: 4.130

5.  Molecular pathology of primary intraocular lymphoma.

Authors:  Chi-Chao Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2003

Review 6.  Primary vitreoretinal lymphoma: prevalence, impact, and management challenges.

Authors:  Ramesh Venkatesh; Bharathi Bavaharan; Padmamalini Mahendradas; Naresh Kumar Yadav
Journal:  Clin Ophthalmol       Date:  2019-02-14

7.  CNS Lymphoma: Clinical Pearls and Management Considerations.

Authors:  Michelot Michel; Noelle Lucke-Wold; Mohammad Reza Hosseini; Eric Panther; Ramya Reddy; Brandon Lucke-Wold
Journal:  Biomed Res Clin Rev       Date:  2022-06-27

Review 8.  Recent progress in the diagnosis and treatment of primary vitreoretinal lymphoma.

Authors:  Min Zhou; Gezhi Xu
Journal:  Taiwan J Ophthalmol       Date:  2016-06-27

9.  The value of bone marrow biopsy for staging of patients with primary CNS lymphoma.

Authors:  Michelle Margold; Sabine Seidel; Thomas Kowalski; Swetlana Ladigan-Badura; Alexander Baraniskin; Roland Schroers; Anna Verena Frey; Ingo G H Schmidt-Wolf; Ulrich Herrlinger; Agnieszka Korfel; Uwe Schlegel
Journal:  Neuro Oncol       Date:  2021-12-01       Impact factor: 12.300

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.